Arkolith/Insider Trading/CTXR/Form 4

Mazur Leonard L

Chief Executive Officer, DirectorCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Sep 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2025Grant(A)125K——125K
Aug 8, 2025Disposed to issuer(D)89K——0
Aug 8, 2025Grant(A)89K——89K
Aug 8, 2025Disposed to issuer(D)125K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-090602) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML